Pharmagreen Biotech Inc. announced earnings results for the third quarter ended June 30, 2021. For the third quarter, the company announced net loss was USD 142,145 compared to USD 1.360 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.02 a year ago. For the nine months, net loss was USD 3.700 million compared to USD 1.570 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.